PsychU

Integration Of Behavioral Health Care & Primary Health Care: The Past, The Present & The Future
2020-10-08 15:00 - 16:00 (America/New_York)

Screening & Treatment Of Maternal Mood & Anxiety Disorders: Tools & Steps To Enhance Treatment Engagement
2020-10-29 12:00 - 13:00, 2020-10-29 15:00 - 16:00

Technology Update: Impacts On Treatment
2020-11-04 12:00 - 13:00

Neuropsychiatric Symptoms (NPS) During COVID-19
2020-11-10 12:00 - 13:00

Addressing Racial Bias In Healthcare: Practice & Organizational Perspectives
2020-11-17 12:00 - 13:00, 2020-11-17 15:00 - 16:00

COVID-19: Perspectives Of The Health Care Provider As The Patient
2020-12-01 12:00 - 13:00

A Recovery-Oriented Perspective & Approach To Behavioral Health Care: A Discussion Among A Peer, A Clinical Provider, & An Advocate (ROPA Series 1)
2021-01-12 12:00 - 13:00

The Impact Of Pandemics On Well-being: Implications For Healthcare Systems & Providers
2021-01-26 12:00 - 13:00

A Recovery-Oriented Perspective & Approach To Behavioral Health Care: A Discussion Among A Peer & A Clinical Provider (ROPA Series Part 2)
2021-02-11 12:00 - 13:00
Home

Events

Webinar

A Recovery-Oriented Perspective & Approach To Behavioral Health Care: A Discussion Among A Peer & A Clinical Provider (ROPA Series Part 2)

Recovery is possible for most individuals living with a mental health condition and this is a process that can improve their health and wellness; live a self-directed life; and work towards achieving their full potential. In this webinar, Alison A. Carroll, LCSW-R provides her clinical perspective, and Dwayne Mayes, MS provides his peer perspective on engaging individuals with mental health conditions using recovery-oriented approaches.

Featuring

,

Becky Wong, PharmD, MBA
Medical Science Director

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

View Flyer (PDF)

Register

This event registration is closed.

Cultural Competence In Healthcare: Laying The Foundation
2021-02-18 12:00 - 13:00

Cultural Competence In Healthcare: Laying The Foundation
2021-02-18 15:00 - 16:00
Cultural Competence In Healthcare: Laying The Foundation

Delivering high-quality and equitable care to an increasingly diverse population is a challenge faced by individual healthcare providers and healthcare systems. Cultural competence has been described as an approach to reduce disparities and improve healthcare quality within the healthcare system. But what exactly is cultural competence?

Drs. Valerie Purdie-Greenaway and Elizabeth Bennett will answer this question and more as they discuss the origin of cultural competence and how tailoring healthcare delivery to meet the social, cultural, and linguistic needs of individual patients may not only improve the patient-provider relationship but also lead to improved outcomes.

During this webinar, they will review the key building blocks of cultural competence, including cultural awareness, knowledge, skill, desire, and encounters. Finally, Drs Purdie-Greenaway and Bennett will introduce the concept of cultural humility and discuss how this dynamic and lifelong process can be used to enrich cultural competence.

Objectives:

The definition of cultural competenceWhy cultural competence is important in healthcareThe origins of cultural competence as a conceptThe components of cultural competenceHow cultural humility relates to cultural competence

Featuring

Kimberly Lonergan, RN, MSN (OPDC)
Regional Medical Lead

Mark Tacelosky, PharmD
Senior Medical Science Liaison

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Addressing Racial Disparities In Healthcare For Black Americans: Bridging The Gap & Changing The Trajectory
2021-02-24 12:00 - 13:00

Addressing Racial Disparities In Healthcare For Black Americans: Bridging The Gap & Changing The Trajectory
2021-02-24 15:00 - 16:00
Home

Events

Webinar

Addressing Racial Disparities In Healthcare For Black Americans: Bridging The Gap & Changing The Trajectory

Please join us for this timely discussion honoring Black History Month with three speakers on the topic of racial disparities in the provision of healthcare in the Black American community. Harriet A. Washington, Dr. William Lawson, and Dr. David Smith will discuss the issues facing the Black community arising from decades of systemic inequality.

Featuring

Hasib H. Bhojwani, MD (OPDC)
Medical Science Liaison

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

View Flyer (PDF)

Register

This event registration is closed.

A Shot For Bipolar I Disorder? Identifying Appropriate Patient Profiles For Maintenance Therapy With Long Acting Injectable Medications
2021-03-30 12:00 - 13:00, 2021-03-30 18:00 - 19:00

Neuropsychiatric Symptoms in Alzheimer’s Disease: A Focus on Agitation
2021-04-08 12:00 - 13:00
Home

Events

Webinar

Neuropsychiatric Symptoms in Alzheimer’s Disease: A Focus on Agitation

Click here to register for the 3:00 pm ET rebroadcast. Please note: Due to high levels of interest, please access this webinar via your computer.

Please join us for this discussion on neuropsychiatric symptoms in Alzheimer’s disease, with a focus on agitation. Drs. Jeffrey Cummings, George Grossberg, and Bryan Archuleta will review the definition of agitation in Alzheimer’s Disease, discuss its potential consequences, and provide an overview of clinical management strategies.

Featuring

Bryan Archuleta, PharmD
Senior Long-Term Care Medical Science Liaison

George T. Grossberg, MD
St Louis University School of Medicine, St Louis, MS

St Louis University School of Medicine, St Louis, MS

Jeffrey Cummings, MD, ScD
Professor of Neurology, Cleveland Clinic Lou Ruvo Center for Brain Health

Drs. Cummings and Grossberg are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.rnDr. Archuleta is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

View Flyer (PDF)

Register

This event registration is closed.

Neuropsychiatric Symptoms in Alzheimer’s Disease: A Focus on Agitation
2021-04-08 15:00 - 16:00
Home

Events

Webinar

Neuropsychiatric Symptoms in Alzheimer’s Disease: A Focus on Agitation

Click here to register for the 12:00 pm ET broadcast. Please note: Due to high levels of interest, please access this webinar via your computer.

Please join us for this discussion on neuropsychiatric symptoms in Alzheimer’s disease, with a focus on agitation. Drs. Jeffrey Cummings, George Grossberg, and Bryan Archuleta will review the definition of agitation in Alzheimer’s Disease, discuss its potential consequences, and provide an overview of clinical management strategies.

Featuring

Bryan Archuleta, PharmD
Senior Long-Term Care Medical Science Liaison

George T. Grossberg, MD
St Louis University School of Medicine, St Louis, MS

St Louis University School of Medicine, St Louis, MS

Jeffrey Cummings, MD, ScD
Professor of Neurology, Cleveland Clinic Lou Ruvo Center for Brain Health

Drs. Cummings and Grossberg are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.rnDr. Archuleta is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Perspectives on International Guidelines for Depression
2021-04-14 12:00 - 13:00
Home

Events

Webinar

Perspectives on International Guidelines for Depression

Click here to register for the 8:00 pm ET broadcast. Please note: Due to high levels of interest, please access this webinar via your computer.

Clinical depression is a challenging diagnosis across the world. International Consensus Guidelines have been developed by key thought leaders to share perspectives on management of depression. Join Drs. Mel Noke and Rachel Self, Medical Science Liaisons for Otsuka in Australia and America, respectively, as they moderate a robust discussion between Dr. Gin Mahli from Australia, Dr. Sagar Parikh from the US and Canada, and Dr. Roger McIntyre from Canada on their perspectives of the guideline development, with a focus on key similarities and differences.

Featuring

Gin Mahli, MD
Executive and Clinical Director of the CADE Clinic Royal North Shore Hospital, Head of the Discipline of Psychiatry at University of Sydney, President of International Society of Bipolar Disorders

Executive and Clinical Director of the CADE Clinic Royal North Shore Hospital, Head of the Discipline of Psychiatry at University of Sydney, President of International Society of Bipolar Disorders

Sagar Parikh, MD, FRCPC
John F Greden Professor of Depression and Clinical Neuroscience, Professor of Psychiatry, Associate Director, University of Michigan Depression Center

John F Greden Professor of Depression and Clinical Neuroscience, Professor of Psychiatry, Associate Director, University of Michigan Depression Center

Roger S. McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology, University of Toronto,
Head of the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada

Mel Noke, PhD
Medical Science Liaison, Otsuka Pharmaceutical Australia Pty Ltd.

Medical Science Liaison, Otsuka Pharmaceutical Australia Pty Ltd.

Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs

Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Perspectives on International Guidelines for Depression
2021-04-14 20:00 - 21:00

Perspectives on International Guidelines for Depression
2021-04-14 20:00 - 21:00
Home

Events

Webinar

Perspectives on International Guidelines for Depression

Click here to register for the 12:00 pm ET broadcast. Please note: Due to high levels of interest, please access this webinar via your computer.

Clinical depression is a challenging diagnosis across the world. International Consensus Guidelines have been developed by key thought leaders to share perspectives on management of depression. Join Drs. Mel Noke and Rachel Self, Medical Science Liaisons for Otsuka in Australia and America, respectively, as they moderate a robust discussion between Dr. Gin Mahli from Australia, Dr. Sagar Parikh from the US and Canada, and Dr. Roger McIntyre from Canada on their perspectives of the guideline development, with a focus on key similarities and differences.

Featuring

Gin Mahli, MD
Executive and Clinical Director of the CADE Clinic Royal North Shore Hospital, Head of the Discipline of Psychiatry at University of Sydney, President of International Society of Bipolar Disorders

Executive and Clinical Director of the CADE Clinic Royal North Shore Hospital, Head of the Discipline of Psychiatry at University of Sydney, President of International Society of Bipolar Disorders

Sagar Parikh, MD, FRCPC
John F Greden Professor of Depression and Clinical Neuroscience, Professor of Psychiatry, Associate Director, University of Michigan Depression Center

John F Greden Professor of Depression and Clinical Neuroscience, Professor of Psychiatry, Associate Director, University of Michigan Depression Center

Roger S. McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology, University of Toronto,
Head of the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada

Mel Noke, PhD
Medical Science Liaison, Otsuka Pharmaceutical Australia Pty Ltd.

Medical Science Liaison, Otsuka Pharmaceutical Australia Pty Ltd.

Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs

Dr. Mel Noke is an employee of Otsuka Pharmaceutical Australia Pty Ltd.rnDr. Rachel Self is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.rnDr. Gin Mahli, Dr. Sagar Parikh, and Dr. Roger McIntyre are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Transforming Care Delivery: Implementing Integrated Behavioral Health Care in The Real World
2021-04-21 12:00 - 13:00
Home

Events

Webinar

In October 2020, nine key thought leaders representing disparate sectors of the health care system—from advocacy, primary care, criminal justice, and academia— gathered online over two days in a “Bridging the Care Continuum” National Forum, to discuss challenges and opportunities in providing integrated mental services in a sometimes fragmented and discontinuous treatment system. In this webinar, three of the thought leaders from the forum will meet again to recap key topics, with particular emphasis the application of continuous and integrated interventions in real world clinical settings. Brandon Kitay, MD, PhD, Integrated Behavioral Health Integration at Emory Healthcare, will lead the discussion along with Henry Chung, Senior Medical Director for Behavioral Health Integration Strategy of Montefiore Care Management Organization, and John Kern, Professor in the Department of Psychiatry and Behavioral Sciences at the University of Washington Advancing Integrated Mental Health Solutions (AIMS) Center. Please join us as they discuss their journeys in Transforming Care Delivery in clinical practice.

Featuring

Brandon Kitay, MD, PhD
Director of Behavioral Health Integration, Emory Healthcare
Assistant Professor of Psychiatry and Behavioral Sciences, Emory University School of Medicine

Henry Chung, MD
Senior Medical Director for Behavioral Health Integration Strategy, Montefiore Care Management Organization
Professor of Psychiatry, Albert Einstein College of Medicine

John Kern, MD
Clinical Professor, Department of Psychiatry and Behavioral Sciences, University of Washington Advancing Integrated Mental Health Solutions (AIMS) Center

Roland Larkin, PhD, MBA, NP (OPDC)
Senior Medical Science Liaison

Dr. Brandon Kitay, Dr. Henry Chung, and Dr. John Kern are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.rnDr. Roland Larkin is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Stigma In Mental Health and Substance Use Disorder
2021-04-29 12:00 - 13:00
Home

Events

Webinar

Please join us for this discussion surrounding stigma as it relates to mental health and substance use disorder. During this PsychU webinar roundtable, our speakers will address the barriers of individual and systemic stigma in these settings as well as offer discussion around lived experience.

Featuring

Michael Measom, MD
Medical Director, Assertive Community Treatment (ACT), Volunteer of America, Salt Lake City, Utah

Michael Measom, MD, Medical Director, Assertive Community Treatment (ACT), Volunteer of America, Salt Lake City, Utah

Wesley Geminn, PharmD
Chief Pharmacist, TN Dept. Of Mental Health and Substance Abuse Services, Nashville, Tennessee

Wesley Geminn, PharmD, is Chief Pharmacist, TN Dept. Of Mental Health and Substance Abuse Services, Nashville, Tennessee

Stephen Loyd, MD
Medical Director Cedar Recovery, Mt. Juliet, Tennessee

Stephen Loyd, MD, Medical Director Cedar Recovery, Mt. Juliet, Tennessee

Jason Carter, PharmD
Senior Medical Science Liaison, Neuroscience Field Medical Affairs

Speakers are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.

View Flyer (PDF)

Register

This event registration is closed.

Nurse Wellness: A Call To Action
2021-05-06 12:00 - 13:00
Home

Events

Webinar

Nurse Wellness: A Call To Action

Worldwide, nurses are on the frontlines caring for the sick and injured of society. The presence of COVID-19 and the global pandemic have shined a light on nurses’ heroic efforts to mend the emotional and physical wounds of patients and their families. Their dedication, selflessness, and sacrifice can come with serious costs to the nurses themselves, their families, and beyond. Consistent with the fourth aim of healthcare1 “to improve the work life of health care providers, including clinicians and staff”- this webinar will emphasize the pressing need for self-care among all nurses, with specific advice and guidance about what to do, how to do it, and why wellness matters. Please join Kim Lonergan, Otsuka Senior MSL and our Section Advisors, Alan “Tony” Amberg and Sara Jones, as they lead a discussion around this timely and important topic.

Featuring

Alan "Tony" Amberg, MS, MSN, APRN, PMHNP-BC
PsychU Nurses Corner Section Advisor, as well as a Psychiatric Consult Liaison Psychiatric Nurse Practitioner at Northwestern Memorial Hospital in Chicago

Sara Jones, PhD, APRN, PMHNP-BC, FAANP, PhD, APRN, PMHNP-BC, FAANP
Associate Professor, University of Arkansas for Medical Sciences (UAMS) College of Nursing; Owner, Psychiatric Mental Health Nurse Practitioner (PMHNP), Journey Wellness Clinic, North Little Rock, AR; Specialty Coordinator, PMHNP program, UAMS College of Nursing; Fellow, American Association of Nurse Practitioners (FAANP), Indianapolis, IN; Founder and Former President, Arkansas Chapter, American Psychiatric Nurses Association

Kimberly Lonergan, RN, MSN (OPDC)
Regional Medical Lead

Alan “Tony” Amberg, MS, MSN, APRN, PMHNP-BC and Sara Jones, PhD, APRN, PMHNP-BC, FAANP are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. Kim Lonergan, RN, MSN is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

Telepsychiatry In Dialysis Patients: A Dream Or A Reality?
2021-05-11 12:00 - 13:00
Home

Events

Webinar

Telepsychiatry In Dialysis Patients: A Dream Or A Reality?

Depression is the most common mental health illness in patients with kidney failure. The reported prevalence of depression in the dialysis population varies widely and can be as high as approximately 40%.1 Join us for a conversation with Dr Shirazian and Dr Behrens as we explore the utility of telepsychiatry in patients undergoing hemodialysis, potential barriers, and the importance of addressing mental health in patients with chronic kidney disease.

Reference

1 King-Wing Ma T, Kam-Tao Li P. Depression in dialysis patients. Nephrology. 2016 Aug;21(8):639-46.

*Drs Shayan Shirazian and Jake Behrens are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Tazin Aijaz is an employee of OPDC.

Featuring

Shirazian Shayan, MD
Assistant Professor of Medicine, Division of Nephrology

Jake Behrens, MD
CEO & Medical Director, Regional Director
Envision ADHD, Brightside Health

Aijaz Tazin, PharmD, BCPS
Nephrology Senior Medical Science Liaison
Otsuka Pharmaceutical Development & Commercialization, Inc.*

Register

This event registration is closed.

Telepsychiatry In Dialysis Patients: A Dream Or A Reality?
2021-05-11 18:00 - 19:00
Home

Events

Webinar

Telepsychiatry In Dialysis Patients: A Dream Or A Reality?

Depression is the most common mental health illness in patients with kidney failure. The reported prevalence of depression in the dialysis population varies widely and can be as high as approximately 40%.1 Join us for a conversation with Dr Shirazian and Dr Behrens as we explore the utility of telepsychiatry in patients undergoing hemodialysis, potential barriers, and the importance of addressing mental health in patients with chronic kidney disease.

Please note: Due to high levels of interest, please access this webinar via your computer.

Reference

1 King-Wing Ma T, Kam-Tao Li P. Depression in dialysis patients. Nephrology. 2016 Aug;21(8):639-46.

*Drs Shayan Shirazian and Jake Behrens are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Tazin Aijaz is an employee of OPDC.

Featuring

Shirazian Shayan, MD
Assistant Professor of Medicine, Division of Nephrology

Jake Behrens, MD
CEO & Medical Director, Regional Director
Envision ADHD, Brightside Health

Aijaz Tazin, PharmD, BCPS
Nephrology Senior Medical Science Liaison
Otsuka Pharmaceutical Development & Commercialization, Inc.*

Register

This event registration is closed.

Mental Health Journey: Voices From Individuals With Lived Experience On Self-Disclosure, Recovery, & Hope
2021-05-13 12:00 - 13:00
Home

Events

Webinar

Mental Health Journey: Voices From Individuals With Lived Experience On Self-Disclosure, Recovery, & Hope

Talking about mental illness can be risky and challenging for many who are suffering from a mental health condition. In this webinar, hear from individuals with lived experience on their self-disclosure challenges and barriers, how they incorporate wellness strategies into their daily lives, and share their individualize recovery journeys and approaches in addressing and overcoming mental health self-stigma.

Please note: Due to high levels of interest, please access this webinar via your computer.

Featuring

John Budin, MD (he/him)
Serving on the Board of Directors of the Depression and Bipolar Support Alliance

,

Caroline Harris, MSW, LCSWA
Hospice Home Clinical Social Worker Associate at Hospice of the Piedmont in North Carolina

Becky Wong, PharmD, MBA
Medical Science Director

John Budin, MD, Dwayne Mayes, MS and Caroline Harris MSW, LCSWA are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Becky Wang, PharmD, BCPP, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

The Human Social Brain: Alterations In Schizophrenia
2021-05-24 12:00 - 12:30
Home

Events

Webinar

In this webinar, Dr. Michael Green and Dr. Stephen Marder will discuss alterations in schizophrenia. Both Drs. Green and Marder are past recipients of the Lieber Prize, awarded for outstanding achievements in schizophrenia research. The webinar discussion will revolve around social cognition and its role in the everyday functioning for patients affected with schizophrenia. Social cognition underlies everyday tasks crucial for social connection, such as reading emotions in others’ faces or making inferences as to what others are thinking.

Drs. Green and Marder will consider key questions including: Is social cognition related to daily functioning in schizophrenia? What is the social brain? Can improved social cognition lead to better functional outcomes? Register today to hear the discussion on the latest research findings.

Click here to register for the 3:00 pm ET rebroadcast. Please note: Due to high levels of interest, please access this webinar via your computer.

Featuring

Michael F. Green, PhD
Professor, Department of Psychiatry and Biobehavioral Sciences and the Semel Institute for Neuroscience and Human Behavior at the Geffen School of Medicine at UCLA,
Director of the VA Research Enhancement Award Program (REAP) on Enhancing Community Integration for Homeless Veterans,
Director of the Treatment Unit of the VA Desert Pacific Mental Illness Research, Education, and Clinical Center (MIRECC)

Stephen R. Marder, MD
Vice Chair of Education, Department of Psychiatry and Biobehavioral Sciences and the Semel Institute for Neuroscience and Human Behavior at the Geffen School of Medicine at UCLA, Daniel X. Freedman Professor of Psychiatry, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA,
Director, VISN 22 Mental Illness Research, Education, and Clinical Center,
Director, Section on Psychosis, Semel Institute for Neuroscience at UCLA

Dri Wang, PharmD, BCPP (OPDC)
Medical Science Liaison

Dr. Michael Green and Dr. Stephen Marder are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Dri Wang, PharmD, BCPP, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.

The Human Social Brain: Alterations In Schizophrenia
2021-05-24 15:00 - 15:30
Home

Events

Webinar

In this webinar, Dr. Michael Green and Dr. Stephen Marder will discuss alterations in schizophrenia. Both Drs. Green and Marder are past recipients of the Lieber Prize, awarded for outstanding achievements in schizophrenia research. The webinar discussion will revolve around social cognition and its role in the everyday functioning for patients affected with schizophrenia. Social cognition underlies everyday tasks crucial for social connection, such as reading emotions in others’ faces or making inferences as to what others are thinking.

Drs. Green and Marder will consider key questions including: Is social cognition related to daily functioning in schizophrenia? What is the social brain? Can improved social cognition lead to better functional outcomes? Register today to hear the discussion on the latest research findings.

Click here to register for the 12:00 pm ET rebroadcast. Please note: Due to high levels of interest, please access this webinar via your computer.

Featuring

Michael F. Green, PhD
Professor, Department of Psychiatry and Biobehavioral Sciences and the Semel Institute for Neuroscience and Human Behavior at the Geffen School of Medicine at UCLA,
Director of the VA Research Enhancement Award Program (REAP) on Enhancing Community Integration for Homeless Veterans,
Director of the Treatment Unit of the VA Desert Pacific Mental Illness Research, Education, and Clinical Center (MIRECC)

Stephen R. Marder, MD
Vice Chair of Education, Department of Psychiatry and Biobehavioral Sciences and the Semel Institute for Neuroscience and Human Behavior at the Geffen School of Medicine at UCLA, Daniel X. Freedman Professor of Psychiatry, Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at UCLA,
Director, VISN 22 Mental Illness Research, Education, and Clinical Center,
Director, Section on Psychosis, Semel Institute for Neuroscience at UCLA

Dri Wang, PharmD, BCPP (OPDC)
Medical Science Liaison

Dr. Michael Green and Dr. Stephen Marder are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. Dri Wang, PharmD, BCPP, is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Register

This event registration is closed.
